Vitro Diagnostics dba Vitro Biopharma (VOGD) develops and commercialize adult stem cell technology for applications in stem cell research, drug development and therapeutic products for treatment a vast variety of diseases and conditions. We offer a series of tools to promote the development of stem cell research and clinical applications focusing on Mesenchymal Stem Cells (MSCs).
Vitro Biopharma provides high quality stem cells produced under strict quality control in a cGMP, ISO9001 & ISO13485 Certified environment. Our umbilical cord AlloRx™ Stem Cells and stem cell growth media MSC-Gro™ have been used in patients to treat of COPD, osteoarthritis, multiple sclerosis and Alzheimer’s disease. From years of research, we developed our patent pending and proprietary line of umbilical cord derived mesenchymal stem cells, AlloRx™ Stem Cells now being used in offshore regenerative medicine clinical trials. Vitro Biopharma has a patent pending, proprietary and scalable manufacturing platform to provide stem cell therapies to critically ill Coronavirus patients.
Modern stem cell technology is rapidly evolving and holds promise to revolutionize medicine by allowing regeneration of any type of cell within the human body. Vitro Biopharma provides commercialized cell lines, media, stem cell products and stem cell technology to some of the world leading institutions. Become a Vitro Biopharma investor today. Call (1)866-848-7627 or email email@example.com or leave us a message here.